Ravindra Rathi

Ravindra Rathi currently serves as the Head of FP&A at Immuneel Therapeutics Pvt. Ltd., where responsibilities include launching CAR-T cancer therapy in India and managing the company's transition to commercialization and IPO. Prior experience includes key roles at Wayfair as EU Cost Optimization Head, enhancing profitability through analytical tools, and an extensive tenure at PepsiCo, where achievements included spearheading transformation initiatives, identifying new business opportunities, and leading investment and commercialization efforts. Ravindra's career also encompasses finance roles at Merck, Constellation Energy, and A.T. Kearney, contributing to financial assessments, capital structure planning, and project management. Educational qualifications include an MBA from Carnegie Mellon University and advanced degrees in Chemical Engineering from the University of Nebraska-Lincoln and RV College of Engineering.